Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C (BHFAN)

FairStock Score: 58/100 — STEADY

Key Financials

Strengths

• Revenue growth of 46.0% demonstrates strong top-line momentum
• Attractive 10.3% dividend yield providing steady income returns

Concerns

• Weak Piotroski F-Score of 1/9 suggests deteriorating financial quality across multiple dimensions

AI Analysis

Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C is a micro-cap financial services company. The business generates $6.9 billion in annual revenue with a 1.6% net margin. From a quality standpoint, Brighthouse shows weak Piotroski F-Score of 1/9 signaling deteriorating fundamentals and modest 7% ROE. On valuation, the stock is deeply undervalued on a P/E basis at 1.0x, with offers a 93% margin of safety vs Graham Number of $183. Growth dynamics show revenue growing at 46.0% and profit growth of -79.6%. The 10.3% dividend yield adds an income component for patient holders. Our composite FairStock Score of 58/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Brighthouse's 46% revenue growth trajectory could accelerate as it captures additional market share in the financial services sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the financial services space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer